Orello: a tool to change the conversation about prostate cancer
|7th February 2018
Last year, Blue Latitude Health partnered with Janssen to launch Orello, a service designed to improve the lives of late-onset prostate cancer patients and their carers. The service was based on understanding patient's unmet emotional and psychological needs.
By grounding the project in detailed insights, we were able to facilitate important but challenging conversations between patients, carers and healthcare professionals.
In January, we presented the service at the PM Society with the below poster, which details the steps we took to support patients and their families, improving their quality of life.
*Click on the poster to expand and print.
Our content has moved
|18th November 2020
We’re posting all new articles on our parent website fishawack.com
Fishawack Health launches Delta Magazine
|17th November 2020
Our parent company Fishawack Health has launched a new magazine with a first issue unpacking rare disease.
In the precision medicine era, the line between products and services is blurred
|27th August 2020
Precision and personalised medicines are more than products, they are services in their own right. So, how should pharma approach this uncharted territory to ensure targeted therapies work for patients?